Charles Donnelly

A pharmacokinetics phase 1 bioequivalence study of the trastuzumab biosimilar MYL‐1401O <i>vs</i>. EU‐trastuzumab and US‐trastuzumab

Cornelius F. Waller, Apinya Vutikullird, Tracey E. Lawrence et al. · British Journal of Clinical Pharmacology · 2018 · 29 citations · Full text

Pharmacokinetic and pharmacodynamic bioequivalence of proposed biosimilar MYL‐1501D with US and European insulin glargine formulations in patients with type 1 diabetes mellitus

Tim Heise, Charles Donnelly, Abhijit Barve et al. · Diabetes Obesity and Metabolism · 2019 · 13 citations · Full text

Pharmacokinetic and pharmacodynamic bioequivalence of biosimilar <scp>MYL‐1601D</scp> with <scp>US</scp> and <scp>European</scp> insulin aspart in healthy volunteers: A randomized, double‐blind, crossover, euglycaemic glucose clamp study

Ulrike Hövelmann, Yaron Raiter, Anoop Chullikana et al. · Diabetes Obesity and Metabolism · 2021 · 13 citations · Full text